Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Biochem J. 2012 Jan 15;441(2):541-52. doi: 10.1042/BJ20111240.
PDAC (pancreatic ductal adenocarcinoma) is among the most deadly of human malignances. A hallmark of the disease is a pronounced collagen-rich fibrotic extracellular matrix known as the desmoplastic reaction. Intriguingly, it is precisely these areas of fibrosis in which human PDAC tumours demonstrate increased expression of a key collagenase, MT1-MMP [membrane-type 1 MMP (matrix metalloproteinase); also known as MMP-14]. Furthermore, a cytokine known to mediate fibrosis in vivo, TGF-β1 (transforming growth factor-β1), is up-regulated in human PDAC tumours and can promote MT1-MMP expression. In the present review, we examine the regulation of PDAC progression through the interplay between type I collagen (the most common extracellular matrix present in human PDAC tumours), MT1-MMP and TGF-β1. Specifically, we examine the way in which signalling events through these pathways mediates invasion, regulates microRNAs and contributes to chemoresistance.
胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)是人类恶性肿瘤中最致命的肿瘤之一。该疾病的一个显著特征是富含胶原蛋白的纤维性细胞外基质,即所谓的促结缔组织增生反应。有趣的是,正是在这些纤维化区域中,人类 PDAC 肿瘤表现出关键胶原酶 MT1-MMP[膜型 1 MMP(基质金属蛋白酶);也称为 MMP-14]的表达增加。此外,体内介导纤维化的细胞因子 TGF-β1(转化生长因子-β1)在人类 PDAC 肿瘤中上调,并能促进 MT1-MMP 的表达。在本综述中,我们通过检查 I 型胶原蛋白(在人类 PDAC 肿瘤中最常见的细胞外基质)、MT1-MMP 和 TGF-β1 之间的相互作用,来研究 PDAC 进展的调控。具体来说,我们研究了这些途径中的信号事件通过何种方式介导侵袭、调节 microRNA 并促进化疗耐药性。